Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD

This study has been completed.
Sponsor:
Information provided by:
Regeneron Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00383370
First received: October 2, 2006
Last updated: April 20, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)